Study Evaluating the Mass Balance And Biotransformation of Single Dose[14C] AST2818 in Chinese Healthy Male Volunteers
Clinical trial NCT03941340 · COMPLETED
Trial details
- NCT number
- NCT03941340
- Sponsor
- Allist Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-08
- Primary completion
- 2019-09-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.